Latest features

Most popular

CPD Articles


  • First ready-to-use toxin to launch

    Pharmaceutical company Galderma has confirmed the first ready-to-use liquid neuromodulator has completed its European decentralised trial in Europe.

  • Speciality responds to JCCP plan

    Practitioners from across the field of aesthetic medicine have submitted a combined response to the Joint Council for Cosmetic Practitioners’ (JCCP) 10-point plan, released in March.